Boston Scientific accounts are for healthcare professionals only.
Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.
My Boston Scientific account
Access your online applications and manage your customer profile.
Quick Links
Call customer care
As a bariatric surgeon, you always seek the right treatment for each individual case. Your patients living with obesity seek the same thing on their weight loss journey – the right solution when diet and lifestyle changes aren’t enough, and surgery isn’t an option. Endura Weight Loss Solutions is a range of non-surgical weight loss procedures done endoscopically.
The non-surgical TORe procedure helps induce satiety for patients1 after weight regain from previous bariatric surgery. Revise a Roux-en-Y gastric bypass to reduce the size of the gastrojejunal outlet and gastric pouch opening.
The non-surgical ESG procedure has been shown to provide lasting results when combined with diet and lifestyle changes2. Significantly reduce your patient’s stomach capacity to help them feel full sooner.
This non-surgical procedure is designed to jumpstart healthy weight loss. Temporarily place a balloon in your patient’s stomach to encourage portion control and lifestyle and behavior modification3.
See endoscopic procedure product information at bottom of page.
Register now to gain access to clinical data and evidence – and other key resources – for the endobariatric procedures you can incorporate into your practice.
Dr. Brian Dunkin explains how endobariatric procedures can help fill the gap between lifestyle modifications and surgery – even with the growth of GLP-1 medications – for people living with obesity. Register to access
Dr. Brian Dunkin explores why a leading bariatric surgery society now recognizes ESG as an effective option within the obesity treatment pathway, based on a review of evidence across 44 studies and 15,000+ patients. Register to access
Make sure your patients have the information they need on their weight loss journey.
Expand your endobariatric offerings with clinical summaries, dietary guidebooks, and patient brochures in both English and Spanish.
If you’ve previously registered for resources, go to your inbox for the confirmation email from Boston Scientific.
Hear from bariatric surgeons who have integrated endoscopic weight loss procedures into their practices.
Dr. Bob Snow shares insights from his 30-year career transitioning from open to laparoscopic and now endoscopic weight loss procedures.
Dr. Bob Snow is a paid consultant of Boston Scientific.
Dr. John Tann explains how endoscopic weight loss procedures expand treatment options for patients who may not want or qualify for surgery.
Dr. John Tann is a paid consultant of Boston Scientific.
Explore Boston Scientific’s health economics and reimbursement resources, including the Bariatric Surgical Medical Necessity Guide as well as updated information on CPT® and ICD-10 codes, physician RVUs, and Medicare national average reimbursement rates for endobariatric procedures.
Boston Scientific provides coding and payment resources that include commonly used CPT®, ICD-10, and HCPCS codes, RVUs, and Medicare national average reimbursement rates across inpatient, outpatient, office, and ASC settings. View Boston Scientific reimbursement resources
No. The information provided by Boston Scientific is intended for educational purposes only and does not guarantee coverage, coding outcomes, payment, or reimbursement. Providers are responsible for determining medical necessity and submitting appropriate claims.
PASP supports the patient’s pathway to coverage through eligibility and benefit verification and prior authorization efforts, including available levels of appeal and external review when permitted by the payer. For PASP resources and information: Visit Boston Scientific reimbursement resources
Common endobariatric procedures include:
Endoscopic Sleeve Gastroplasty (ESG)
Transoral Outlet Reduction (TORe)
Intragastric balloon placement
Boston Scientific offers OverStitch™ endoscopic suturing for ESG and TORe procedures, as well as the ORBERA™ Intragastric Balloon System for weight loss therapy.
Eligibility varies by procedure and individual patient factors, but generally includes adults with obesity seeking weight loss. See the IFU for each product for specific procedure requirements. All IFUs can be found at www.IFU-BSCI.com.
We’re here to support physicians and patients with the tools, insights, and information needed to make the right clinical decision.
Explore EDUCARE on-demand courses and product training on endobariatric procedures.
OverStitch™ Endoscopic Suturing System ESS Indications, Safety, and Warnings
OverStitch NXT™ Endoscopic Suturing System ESS Indications, Safety, and Warnings
OverStitch™ 2-0 Polypropylene Suture Assembly Indications, Safety, and Warnings
Orbera™ Intragastric Balloon Indications, Safety, and Warnings
*Both the OverStitch NXT, OverStitch Endoscopic Suturing Systems (when used for ESG and TORe) and Orbera Intragastric balloon procedures should be conducted by physicians who have undergone specific training by the device manufacturer.
Health economic and reimbursement information provided by Boston Scientific Corporation is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice. Boston Scientific encourages providers to submit accurate and appropriate claims for services. It is always the provider's responsibility to determine medical necessity, the proper site for delivery of any services and to submit appropriate codes, charges, and modifiers for services that are rendered. Boston Scientific recommends that you consult with your payers, reimbursement specialists and/or legal counsel regarding coding, coverage and reimbursement matters. Boston Scientific does not promote the use of its products outside their FDA-approved label.
1. Jirapinyo P, Kumar N, AlSamman MA, Thompson CC. Five-year outcomes of transoral outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass. Gastrointest Endosc. 2019;91:1067–1073.
2. Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): A prospective, multicentre, randomised trial. Lancet. 2022;400:441–451.
3. US FDA Pivotal Study. n = 137 Orbera, n = 136 control, p < 0.001. Most of the patients from the US FDA pivotal study were female and Caucasian. Because of this, data from this study may not accurately represent the same effectiveness and safety profile in Hispanic, African American, or other ethnic populations.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
All photographs taken by Boston Scientific.
